Literature DB >> 26411794

Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.

Peter Molenveld1, Renaud Bouzanne des Mazery1, Geert Jan Sterk1, Roy P M Storcken1, Reshma Autar1, Bram van Oss1, Richard N S van der Haas1, Roland Fröhlich2, Dirk Schepmann3, Bernhard Wünsch3, Michael Soeberdt4.   

Abstract

All diastereoisomeric decahydroquinoxalines representing conformationally restricted analogs of κ agonists U-50,488 and GR-89,696 have been prepared. Cis/trans configured compound 7 is by far the highest binding diastereoisomer with a Ki of 0.35 nM. Racemates 4, 6, and 7 were separated into enantiomers. (+)-(4aR,5S,8aS)-Configured enantiomer 7b was identified as a high affinity (Ki=0.25 nM) κ ligand with high selectivity over μ and δ receptors. It acts as full agonist with an EC50 value of 2.0 nM in the [(35)S]GTPγS assay, while enantiomer 7a showed an EC50 value of 1000 nM.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decahydroquinoxalines; Diastereoisomers; Hydrogenation; Relationship between configuration and κ affinity; Resolution of enantiomers; SAR; κ agonists; κ-Opioid receptor

Mesh:

Substances:

Year:  2015        PMID: 26411794     DOI: 10.1016/j.bmcl.2015.09.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids.

Authors:  Xuelian Jia; Heather L Ciallella; Daniel P Russo; Linlin Zhao; Morgan H James; Hao Zhu
Journal:  ACS Sustain Chem Eng       Date:  2021-03-04       Impact factor: 8.198

2.  Enantiomerically Pure Quinoline-Based κ-Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation.

Authors:  Benedikt Martin; Dirk Schepmann; Freddy A Bernal; Thomas J Schmidt; Tao Che; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-07-02       Impact factor: 3.466

3.  Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.

Authors:  Giovanni Tangherlini; Frederik Börgel; Dirk Schepmann; Samuel Slocum; Tao Che; Stefan Wagner; Katrin Schwegmann; Sven Hermann; Nadine Mykicki; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-09-01       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.